| Serial Number | 98674089 |
| Word Mark | TRIGEN |
| Filing Date | Tuesday, July 30, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 9, 2025 |
| Goods and Services | Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Generic pharmaceutical research and development |
| Goods and Services | Full line of pharmaceutical products, namely pharmaceutical products and preparations for treating diseases and conditions in gynecology and women's health, pharmaceutical products and preparations for use as prenatal supplements, pharmaceutical products and preparations for use as iron supplements, pharmaceutical products and preparations for use as multivitamin and mineral supplements, vitamin supplements and nutraceuticals for use as dietary supplements, pharmaceutical products and preparations for treating symptoms associated with menopause, pharmaceutical products and preparations for treating menopause and post menopause symptoms and conditions, pharmaceutical products and preparations for use in pain management, pharmaceutical products and preparations for use as opioid analgesics, pharmaceutical products and preparations for treating musculoskeletal conditions, and pharmaceutical products and preparations for use as a centrally-acting agents for musculoskeletal conditions; pharmaceutical preparations for managing and relieving pain and inflammation, pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis, pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder, and pharmaceutical products and preparations for use as antidepressants |
| Pseudo Mark | TRI GEN |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, October 25, 2013 |
| First Use In Commerce Date | Friday, October 25, 2013 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, October 25, 2013 |
| First Use In Commerce Date | Friday, October 25, 2013 |
| Party Name | Trigen Laboratories, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Alpharetta, GA 30005 |
| Party Name | Trigen Laboratories, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Alpharetta, GA 30005 |
| Event Date | Event Description |
| Tuesday, July 30, 2024 | NEW APPLICATION ENTERED |
| Thursday, January 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 6, 2025 | ASSIGNED TO EXAMINER |
| Thursday, February 6, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, February 6, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, February 6, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 6, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, May 6, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, August 6, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 29, 2025 | FINAL REFUSAL WRITTEN |
| Friday, August 29, 2025 | FINAL REFUSAL E-MAILED |
| Friday, August 29, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, November 10, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, November 10, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 10, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 13, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 3, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 9, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 9, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |